GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BIOGY) » Definitions » E10

BioGaia AB (BioGaia AB) E10 : $0.27 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioGaia AB's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.116. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.27 for the trailing ten years ended in Mar. 2024.

During the past 12 months, BioGaia AB's average E10 Growth Rate was 10.10% per year. During the past 3 years, the average E10 Growth Rate was 10.90% per year. During the past 5 years, the average E10 Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BioGaia AB was 10.90% per year. The lowest was 4.10% per year. And the median was 8.20% per year.

As of today (2024-06-09), BioGaia AB's current stock price is $12.08. BioGaia AB's E10 for the quarter that ended in Mar. 2024 was $0.27. BioGaia AB's Shiller PE Ratio of today is 44.74.

During the past 13 years, the highest Shiller PE Ratio of BioGaia AB was 61.09. The lowest was 32.54. And the median was 43.42.


BioGaia AB E10 Historical Data

The historical data trend for BioGaia AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB E10 Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.25 0.24 0.25 0.28

BioGaia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.23 0.25 0.28 0.27

Competitive Comparison of BioGaia AB's E10

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Shiller PE Ratio falls into.



BioGaia AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioGaia AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.116/132.2054*132.2054
=0.116

Current CPI (Mar. 2024) = 132.2054.

BioGaia AB Quarterly Data

per share eps CPI Adj_EPS
201406 0.031 100.432 0.041
201409 0.024 100.161 0.032
201412 0.027 100.225 0.036
201503 0.059 99.950 0.078
201506 0.050 99.995 0.066
201509 0.028 100.228 0.037
201512 0.029 100.276 0.038
201603 0.148 100.751 0.194
201606 0.053 101.019 0.069
201609 0.047 101.138 0.061
201612 0.059 102.022 0.076
201703 0.055 102.022 0.071
201706 0.063 102.752 0.081
201709 0.061 103.279 0.078
201712 0.066 103.793 0.084
201803 0.060 103.962 0.076
201806 0.073 104.875 0.092
201809 0.066 105.679 0.083
201812 0.082 105.912 0.102
201903 0.044 105.886 0.055
201906 0.075 106.742 0.093
201909 0.045 107.214 0.055
201912 0.062 107.766 0.076
202003 0.049 106.563 0.061
202006 0.097 107.498 0.119
202009 0.026 107.635 0.032
202012 0.048 108.296 0.059
202103 0.059 108.360 0.072
202106 0.064 108.928 0.078
202109 0.060 110.338 0.072
202112 0.042 112.486 0.049
202203 0.079 114.825 0.091
202206 0.078 118.384 0.087
202209 0.072 122.296 0.078
202212 0.133 126.365 0.139
202303 0.110 127.042 0.114
202306 0.074 129.407 0.076
202309 0.091 130.224 0.092
202312 0.065 131.912 0.065
202403 0.116 132.205 0.116

Add all the adjusted EPS together and divide 10 will get our e10.


BioGaia AB  (OTCPK:BIOGY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioGaia AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=12.08/0.27
=44.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of BioGaia AB was 61.09. The lowest was 32.54. And the median was 43.42.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioGaia AB E10 Related Terms

Thank you for viewing the detailed overview of BioGaia AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB (BioGaia AB) Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.